__timestamp | ADMA Biologics, Inc. | Sarepta Therapeutics, Inc. |
---|---|---|
Wednesday, January 1, 2014 | 5915545 | 9757000 |
Thursday, January 1, 2015 | 7177633 | 1253000 |
Friday, January 1, 2016 | 10661037 | 5421000 |
Sunday, January 1, 2017 | 22760560 | 154584000 |
Monday, January 1, 2018 | 16985290 | 301034000 |
Tuesday, January 1, 2019 | 29349083 | 380833000 |
Wednesday, January 1, 2020 | 42219783 | 540099000 |
Friday, January 1, 2021 | 80942625 | 701887000 |
Saturday, January 1, 2022 | 154079692 | 933013000 |
Sunday, January 1, 2023 | 258214999 | 1243336000 |
In pursuit of knowledge
In the dynamic world of biotechnology, revenue growth is a key indicator of a company's success and market influence. Over the past decade, Sarepta Therapeutics, Inc. has consistently outpaced ADMA Biologics, Inc. in annual revenue. Starting in 2014, Sarepta's revenue was nearly double that of ADMA, and by 2023, it had surged to approximately five times ADMA's revenue. This impressive growth trajectory highlights Sarepta's strategic advancements and market penetration.
From 2014 to 2023, Sarepta's revenue increased by over 12,000%, while ADMA saw a growth of around 4,300%. This stark contrast underscores Sarepta's dominant position in the biotech sector. As both companies continue to innovate, investors and industry watchers will be keenly observing how these revenue trends evolve in the coming years.
Annual Revenue Comparison: Merck & Co., Inc. vs ADMA Biologics, Inc.
United Therapeutics Corporation and ADMA Biologics, Inc.: A Comprehensive Revenue Analysis
Revenue Insights: Incyte Corporation and ADMA Biologics, Inc. Performance Compared
Sarepta Therapeutics, Inc. vs Amneal Pharmaceuticals, Inc.: Examining Key Revenue Metrics
Sarepta Therapeutics, Inc. or PTC Therapeutics, Inc.: Who Leads in Yearly Revenue?
Who Generates More Revenue? Sarepta Therapeutics, Inc. or Arrowhead Pharmaceuticals, Inc.
Sarepta Therapeutics, Inc. or Geron Corporation: Who Leads in Yearly Revenue?
Who Generates More Revenue? Sarepta Therapeutics, Inc. or Celldex Therapeutics, Inc.
Comparing Revenue Performance: ADMA Biologics, Inc. or PTC Therapeutics, Inc.?
Annual Revenue Comparison: ADMA Biologics, Inc. vs Veracyte, Inc.
Revenue Insights: ADMA Biologics, Inc. and Bausch Health Companies Inc. Performance Compared
Breaking Down Revenue Trends: ADMA Biologics, Inc. vs Viridian Therapeutics, Inc.